Inventor · disambiguated record
David Karpf
Also filed as: KARPF DAVID · KARPF DAVID B · KARPF DAVID BRIAN
20 granted patents·8 pending applications·154 citations·filing 1995–2025
94Inventor score
Files withCYMABAY THERAPEUTICS INC10ASCENDIS PHARMA BONE DISEASES AS9SPRUCE BIOSCIENCES INC3MERCK & CO INC2MCWHERTER CHARLES A1
Top patents by PatentIndex Score
28 records- 0196US9616039B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2016·Granted Apr 11, 2017·31 cites·12 claims
- 0296US9381181B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2015·Granted Jul 5, 2016·38 cites·6 claims
- 0395US11857603B2PTH compounds with low peak-to-trough ratiosASCENDIS PHARMA BONE DISEASES AS·Filed 2022·Granted Jan 2, 2024·5 cites·12 claims
- 0493US11858932B2Methods and compositions for treating polycystic ovary syndromeSPRUCE BIOSCIENCES INC·Filed 2023·Granted Jan 2, 2024·6 cites·21 claims
- 0592US11759504B2PTH compounds with low peak-to-trough ratiosASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Granted Sep 19, 2023·6 cites·12 claims
- 0691US12098152B2Methods and compositions for treating polycystic ovary syndromeSPRUCE BIOSCIENCES INC·Filed 2023·Granted Sep 24, 2024·3 cites·21 claims
- 0791US11590207B2Dosage regimen for a controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Granted Feb 28, 2023·9 cites·5 claims
- 0891US10188620B2Treatment for NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2018·Granted Jan 29, 2019·7 cites·19 claims
- 0991US9962346B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2017·Granted May 8, 2018·8 cites·13 claims
- 1087US12295989B2Controlled-release PTH compoundASCENDIS PHARMA BONE DISEASES AS·Filed 2024·Granted May 13, 2025·0 cites·5 claims
- 1186US10722483B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2019·Granted Jul 28, 2020·1 cites·19 claims
- 1286US10342770B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·3 cites·19 claims
- 1380US2024173385A1PTH Compounds with Low Peak-To-Trough RatiosASCENDIS PHARMA BONE DISEASES AS·Filed 2023·Application pending·0 cites
- 1477US2025302924A1Controlled-Release PTH CompoundASCENDIS PHARMA BONE DISEASES AS·Filed 2025·Application pending·0 cites
- 1575US2025206733A1Methods and compositions for treating polycystic ovary syndromeSPRUCE BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 1673US11179359B2Treatment of NAFLD and NASHCYMABAY THERAPEUTICS INC·Filed 2020·Granted Nov 23, 2021·0 cites·19 claims
- 1769US11007162B2Methods of reducing small, dense LDL particlesCYMABAY THERAPEUTICS INC·Filed 2018·Granted May 18, 2021·0 cites·10 claims
- 1867US2020360488A1Pth compounds with low peak-to-trough ratiosASCENDIS PHARMA BONE DISEASES AS·Filed 2020·Application pending·0 cites
- 1966US5804570AMethod of lessening the risk of non-vertebral bone fracturesMERCK & CO INC·Filed 1997·Granted Sep 8, 1998·28 cites·16 claims
- 2063US2010152295A1Methods of reducing small, dense ldl particlesMETABOLEX INC·Filed 2009·Application pending·0 cites
- 2152US2021196801A1Starting Dose of PTH ConjugatesASCENDIS PHARMA BONE DISEASES AS·Filed 2019·Application pending·0 cites
- 2250US10098843B2Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineCYMABAY THERAPEUTICS INC·Filed 2016·Granted Oct 16, 2018·0 cites·15 claims
- 2348US12453778B2Incremental dose finding in controlled-release PTH compoundsASCENDIS PHARMA BONE DISEASES AS·Filed 2017·Granted Oct 28, 2025·0 cites·8 claims
- 2447US2016324811A1Methods of reducing small, dense ldl particlesCYMABAY THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2545US9241924B2Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineMCWHERTER CHARLES A·Filed 2011·Granted Jan 26, 2016·0 cites·11 claims
- 2645US5914099APrevention of tooth loss by the administration of alendronate or its saltsMERCK & CO INC·Filed 1996·Granted Jun 22, 1999·9 cites·6 claims
- 2738US8288438B2Methods for avoiding edema in the treatment or prevention of PPARγ-responsive diseases, including cancerSANDERS MARTIN E·Filed 2006·Granted Oct 16, 2012·0 cites·16 claims
- 2824US2001051616A1Method of lessening the risk of vertebral fracturesFiled 1995·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →